Interim Management Statement

IP Group PLC
29 April 2008


FOR RELEASE ON                                                     29 APRIL 2008


                  ('IP Group' or 'the Group' or 'the Company')

                     IP Group: Interim Management Statement


IP Group plc (LSE: IPO), the UK's leading university intellectual property
commercialisation company, today issues its Interim Management Statement in
accordance with FSA Disclosure and Transparency Rule 4.3. This statement
provides an update on the Group's progress since 1 January 2008.

Alan Aubrey, Chief Executive of IP Group, said: 'The Group has made good
progress since the beginning of the year and our portfolio companies continue to
progress towards their commercial and technological goals. We have seen further
evidence of the success of our multi-channel financing network in challenging
financial markets, with the announcement of a significant private funding round
for one of our portfolio companies, Oxford Nanolabs Limited.

Our strong balance sheet position, with a broad spread of portfolio companies
across sector and development stage, enables the Directors to continue to remain
confident of delivering long term shareholder value.'

Portfolio update

During the three months to 31 March 2008, the Group invested a total of £3.0m
into 15 new and existing portfolio companies. During the equivalent period in
2007, the Group invested £1.4m into 7 companies. The Group has not made any
realisations during this three month period.

The 14 companies in the Group's portfolio which are listed on either AIM or PLUS
Markets achieved a net fair value gain of £9.0m during the three months to 31
March 2008. The unquoted portfolio achieved a net fair value gain of £5.1m
during this same period. Portfolio performance for the quarter represents a very
positive start towards achieving our return objectives for the year.

The Group's portfolio companies have made significant technological and
commercial progress during the first three months of the year. By way of
example, Green Chemicals plc announced the successful completion of its field
trials for durable flame retardant products, Syntopix Group plc announced
positive results from a Phase II cosmetic study for acneic skin treatments,
while Ilika Technologies Limited announced that Toyota had selected the company
to accelerate their battery programme and that a research collaboration had been
formed with NXP Semiconductors.

Significant transactions

On 28 March 2008, Oxford Nanolabs Limited, a portfolio company from the
University of Oxford developing a rapid genome sequencing platform, announced
the successful completion of a £10m private financing round, resulting in a
£7.2m fair value gain for the Group. IP Group's 35% beneficial interest in the
newly enlarged share capital of the company is valued at £19.5m.

Corporate update

IP Group is delighted to have announced the appointment of Francis Carpenter to
the Board as a non-executive director. Francis' extensive experience in venture
capital and technology transfer within the European market will be invaluable as
the Group moves towards commencing operations in Europe.

On the fund management side, IP Venture Fund invested £1.05m into two IP Group
portfolio companies during the three months to 31 March 2008 and, as at this
date, had invested a total of £8.6m into 15 IP Group portfolio companies since
its launch in July 2006.

Balance sheet update

At 31 March 2008, the Group had cash and equivalents of £41m and continued to
have no gearing. Overall, the financial and operating performance of the Group
in the period was in line with internal expectations.

Ends


For more information, please contact:

IP Group plc
Alan Aubrey, Chief Executive Officer              020 7444 0050
Mike Townend, Director of Capital Markets         020 7444 0050
Greg Smith, Group Financial Controller            020 7444 0050
Liz Vaughan-Adams, Communications                 020 7444 0062 / 07979 853 802

Financial Dynamics                                020 7831 3113
Ben Atwell, Rob Bailhache

About IP Group

IP Group is an intellectual property (IP) commercialisation company that
specialises in commercialising university technology. Founded in 2001, IP Group
listed on AIM in October 2003 and moved to the Official List in June 2006. It
has made two acquisitions to date - Techtran, a company set up to commercialise
university intellectual property under a long term contract with the University
of Leeds, in 2005 and Top Technology Ventures, an investment adviser to early
stage technology venture capital funds, in 2004.

IP Group has formed long-term partnerships with ten universities - the
University of Oxford, King's College London, CNAP/University of York, the
University of Leeds, the University of Bristol, the University of Surrey, the
University of Southampton, Queen Mary (University of London), the University of
Bath and the University of Glasgow.

The Company's portfolio is diverse with exposure to five main sectors - Energy &
Renewables, Healthcare & Life Sciences: Non-therapeutics, Healthcare & Life
Sciences: Therapeutics, IT & Communications and Chemicals & Materials. To date,
ten portfolio companies have listed on the AIM market of the London Stock
Exchange, one on PLUS Markets and there have been two trade sales. IP Group also
established three 'Modern-themed' subsidiaries - Modern Biosciences, Modern
Water and Modern Waste. Modern Water was the first of these subsidiaries to
float on AIM in June 2007.

For more information, please visit our website: www.ipgroupplc.com



                      This information is provided by RNS
            The company news service from the London Stock Exchange